Frequently Asked Questions
Common Questions About Using ICD-10 Code C86.61 for Primary cutaneous CD30-positive T-cell prolif, in remission
What are the symptoms of Primary cutaneous CD30-positive T-cell prolif?
Symptoms may include erythematous plaques, nodules, and occasional itching. Patients may also report no systemic symptoms, especially when in remission.
How is this condition treated?
Treatment typically involves monitoring and may include topical corticosteroids to manage localized lesions. Regular follow-ups are essential to assess any changes.
Is Primary cutaneous CD30-positive T-cell prolif contagious?
No, Primary cutaneous CD30-positive T-cell proliferation is not contagious. It is a type of lymphoma that arises from abnormal T-cell growth.
When should I seek medical attention?
Patients should seek medical attention if they notice new skin lesions, changes in existing lesions, or experience significant itching or discomfort.
